Jiangsu Lianhuan Pharmaceutical's announcement on the implementation completion of the shareholder's shareholding plan.
Announcement on the progress of jiangsu lianhuan pharmaceutical's controlling shareholder's shareholding of the company's shares and subsequent shareholding plan as well as the action plan of "improving quality and efficiency and returning reward".
Jiangsu Lianhuan Pharmaceutical: Jiangsu Lianhuan Pharmaceutical's plan to issue stocks to specific targets through a simplified process in 2024.
Jiangsu Lianhuan Pharmaceutical: Feasibility analysis report for the use of funds raised through the issuance of stocks to specific objects in easy procedures by Jiangsu Lianhuan Pharmaceutical in 2024.
Jiangsu Lianhuan Pharmaceutical: Jiangsu Lianhuan Pharmaceutical's announcement regarding the preliminary proposal to issue stocks to specific individuals through a simplified procedure for the 2024 fiscal year.
Jiangsu Lianhuan Pharmaceutical: Jiangsu Lianhuan Pharmaceutical's analysis report on the proposal for issuing stocks to specific targets through simplified procedures in 2024.
Lianhuan Pharmaceutical's 2023 Annual Equity Distribution Implementation Notice
Announcement of Lianhuan Pharmaceutical on the company's 2023 profit distribution plan
Lianhuan Pharmaceutical\'s indicative announcement on the controlling shareholder increasing the company\'s shares by more than 1%
Announcement of Lianhuan Pharmaceutical on the controlling shareholder\'s increase in the company\'s shares and the company\'s action plan to “improve quality, increase efficiency and focus on return”
Lianhuan Pharmaceutical Equity Incentives Restricted Stock Repurchase Cancellation Implementation Notice
Lianhuan Pharmaceutical\'s announcement on terminating the implementation of the 2019 Restricted Stock Incentive Plan, adjusting the repurchase price, and repurchasing and cancelling restricted stocks that have been granted but not yet lifted the sale rest
Legal Opinion on Jiangsu Lianhuan Pharmaceutical Co., Ltd.\'s adjustment of the repurchase price of the 2019 restricted stock incentive plan, termination of implementation of the 2019 restricted stock incentive plan, and repurchase and cancellation of rest
Lianhuan Pharmaceutical 2022 Annual Equity Distribution Implementation Notice
Lianhuan Pharmaceutical's announcement on the company's 2022 profit distribution plan
Lianhuan Pharmaceutical's shareholder dividend return plan for the next three years (2022-2024)
Lianhuan Pharmaceutical 2021 Annual Equity Distribution Implementation Notice
Lianhuan Pharmaceutical's announcement on the company's 2021 profit distribution plan
Legal opinion of the Shanghai Branch of Beijing Jingtian Gongcheng Law Firm on the repurchase and cancellation of some restricted stocks by Jiangsu Lianhuan Pharmaceutical Co., Ltd.
Announcement on the Implementation of Lianhuan Pharmaceutical's Equity Incentives and Cancellation of Restricted Stock Repurchase
No Data